A complete application in a minute
Tailored resume and cover letter, ready to send.
Chugai Pharmabody Research Pte. Ltd. in Singapore is seeking a Senior Scientist to join the Mid-size Molecule Unit and advance drug discovery using novel screening and peptide engineering technologies.
Reporting to the Research Manager, you will lead peptide identification and screening activities, develop new screening technologies, and drive projects from concept to in-lab execution while collaborating across research teams. Fresh graduates are welcome to apply.
Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly‑owned subsidiary of Chugai Pharmaceutical Co., Ltd(Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore, it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering technologies, such as recycling antibody®, sweeping antibody®, bispecific antibody, various Fc engineered antibodies, and other new antibody engineering technologies that are under development.
CPR is seeking a motivated Senior Scientist with demonstrated expertise in drug discovery, biotechnology and/or chemical biology, and a strong passion for medical science. This position offers the opportunity to contribute to the discovery and development of innovative drugs by applying and developing novel screening and peptide engineering technologies to address unmet medical needs.
Reporting to the Research Manager, you will work closely with colleagues across research functions to advance drug discovery programmes. Following appropriate onboarding and familiarisation with laboratory instrumentation and experimental workflows, you will be expected to work independently.
For more information regarding our Company, you may refer to our website at:
http://chugai-pharmabody.com/
We regret that only short‑listed candidates will be notified